Reglan

Bold labels are required.

Contact Information

Name

E-mail Address Please enter a valid e-mail address.

Phone

Address

Brief description of your legal issue

Please verify that you have read the disclaimer. I have read the disclaimer. disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

REGLAN® PERSONAL INJURY ATTORNEY

Reglan (metoclopramide) is often prescribed to treat individuals with gastrointestinal problems. In February of 2009, the United States Food and Drug Administration (FDA) issued an advisory requiring the manufactures of Reglan to update their label. The advisory called for a black box warning, the strongest warning issued by the FDA, regarding the risk of individuals developing Tardive Dyskinesia. Tardive Dyskinesia is most often characterized by repetitive, involuntary movements. Tardive Dyskinesia is a devastating and sometimes lifelong syndrome. At this time, there is no know treatment for Tardive Dyskinesia. It is important to know that the FDA has only approved Reglan for short-term use (4 to 12 weeks) and only when conservative treatment fails.

Serious Side-Effects

If you or a loved one have taken Reglan and been diagnosed with Tardive Dyskinesia you may be entitled to compensation for your injuries.

Our attorneys are here to help you obtain compensation for your injuries due to Reglan use. Please contact us today for a Free evaluation by calling James F. Humphreys & Associates, L.C. 1-877-341-2595 or by completing our online form.